Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-July Through September 2021, 64492-64506 [2021-25103]
Download as PDF
64492
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
using a pay-per-call service, that they
will not be liable for unauthorized nontoll charges on their telephone bills, and
how to deal with disputes about
telephone-billed purchases.
Likely Respondents:
telecommunications common carriers
(subject to the reporting requirement
only, unless acting as a billing entity),
information providers (vendors) offering
one or more pay-per-call services or
programs, and billing entities.
Estimated Annual Hours Burden:
1,029,570 hours (18 + 1,029,552).
Reporting: 18 hours for reporting by
common carriers.
Disclosure: 1,029,552 [(21,240 hours
for advertising by vendors + 21,732
hours for preamble disclosure which
applies to every pay-per-call service +
7,080 burden hours for telephone-billed
charges in billing statements (applies to
vendors; applies to common carriers if
acting as billing entity) + 11,500 burden
hours for dispute resolution procedures
in billing statements (applies to billing
entities) + 968,000 hours for disclosures
related to consumers reporting a billing
error (applies to billing entities)].
Estimated annual cost burden:
$50,456,136 (solely relating to labor
costs).1
khammond on DSKJM1Z7X2PROD with NOTICES
Request for Comment
On August 18, 2021, the FTC sought
public comment on the information
collection requirements associated with
the Rule. 86 FR 46254. The Commission
received no germane comments.
Pursuant to the OMB regulations, 5 CFR
part 1320, that implement the PRA, 44
U.S.C. 3501 et seq., the FTC is providing
this second opportunity for public
comment while seeking OMB approval
to renew the pre-existing clearance for
the Rules.
Your comment—including your name
and your state—will be placed on the
public record of this proceeding.
Because your comment will be made
public, you are solely responsible for
making sure that your comment does
not include any sensitive personal
information, such as anyone’s Social
Security number; date of birth; driver’s
license number or other state
identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9132–N]
Medicare and Medicaid Programs;
Quarterly Listing of Program
Issuances—July Through September
2021
Centers for Medicare &
Medicaid Services (CMS), HHS.
AGENCY:
ACTION:
Notice
This quarterly notice lists
CMS manual instructions, substantive
and interpretive regulations, and other
Federal Register notices that were
published from July through September
2021, relating to the Medicare and
Medicaid programs and other programs
administered by CMS.
SUMMARY:
It is
possible that an interested party may
need specific information and not be
able to determine from the listed
information whether the issuance or
regulation would fulfill that need.
Consequently, we are providing contact
persons to answer general questions
concerning each of the addenda
published in this notice.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2021–25104 Filed 11–17–21; 8:45 am]
BILLING CODE 6750–01–P
Addenda
Contact
I CMS Manual Instructions ................................................................................
II Regulation Documents Published in the FEDERAL REGISTER .........................
III CMS Rulings ..................................................................................................
IV Medicare National Coverage Determinations ...............................................
V FDA-Approved Category B IDEs ...................................................................
VI Collections of Information ..............................................................................
VII Medicare-Approved Carotid Stent Facilities .................................................
VIII American College of Cardiology-National Cardiovascular Data Registry
Sites.
IX Medicare’s Active Coverage-Related Guidance Documents ........................
X One-time Notices Regarding National Coverage Provisions .........................
XI National Oncologic Positron Emission Tomography Registry Sites .............
XII Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities.
XIII Medicare-Approved Lung Volume Reduction Surgery Facilities ................
XIV Medicare-Approved Bariatric Surgery Facilities .........................................
XV Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials
All Other Information ............................................................................................
Ismael Torres ........................................
Terri Plumb ...........................................
Tiffany Lafferty ......................................
Wanda Belle, MPA ...............................
John Manlove .......................................
William Parham .....................................
Sarah Fulton, MHS ...............................
Sarah Fulton, MHS ...............................
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
786–1864
786–4481
786–7548
786–7491
786–6877
786–4669
786–2749
786–2749
JoAnna Baldwin, MS ............................
JoAnna Baldwin, MS ............................
David Dolan, MBA ................................
David Dolan, MBA ................................
(410)
(410)
(410)
(410)
786–7205
786–7205
786–3365
786–3365
Sarah Fulton, MHS ...............................
Sarah Fulton, MHS ...............................
David Dolan, MBA ................................
Annette Brewer .....................................
(410)
(410)
(410)
(410)
786–2749
786–2749
786–3365
786–6580
1 Non-labor (e.g., capital/other start-up) costs are
generally subsumed in activities otherwise
undertaken in the ordinary course of business (e.g.,
business records from which only existing
information must be reported to the Commission,
pay-per-call advertisements or audiotext to which
VerDate Sep<11>2014
17:11 Nov 17, 2021
Jkt 256001
cost or other disclosures are added, etc.). To the
extent that entities incur operating or maintenance
expenses, or purchase outside services to satisfy the
Rule’s requirements, staff believe those expenses
are also included in (or, if contracted out, would be
comparable to) the annual burden hour and cost
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Phone number
estimates provided below (where such costs are
labor-related), or are otherwise included in the
ordinary cost of doing business (regarding non-labor
costs).
E:\FR\FM\18NON1.SGM
18NON1
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
SUPPLEMENTARY INFORMATION
I. Background
khammond on DSKJM1Z7X2PROD with NOTICES
The Centers for Medicare & Medicaid
Services (CMS) is responsible for
administering the Medicare and
Medicaid programs and coordination
and oversight of private health
insurance. Administration and oversight
of these programs involves the
following: (1) Furnishing information to
Medicare and Medicaid beneficiaries,
health care providers, and the public;
and (2) maintaining effective
communications with CMS regional
offices, state governments, state
Medicaid agencies, state survey
agencies, various providers of health
care, all Medicare contractors that
process claims and pay bills, National
Association of Insurance Commissioners
(NAIC), health insurers, and other
stakeholders. To implement the various
statutes on which the programs are
based, we issue regulations under the
authority granted to the Secretary of the
Department of Health and Human
Services under sections 1102, 1871,
1902, and related provisions of the
Social Security Act (the Act) and Public
Health Service Act. We also issue
various manuals, memoranda, and
statements necessary to administer and
oversee the programs efficiently.
VerDate Sep<11>2014
17:11 Nov 17, 2021
Jkt 256001
Section 1871(c) of the Act requires
that we publish a list of all Medicare
manual instructions, interpretive rules,
statements of policy, and guidelines of
general applicability not issued as
regulations at least every 3 months in
the Federal Register.
II. Format for the Quarterly Issuance
Notices
This quarterly notice provides only
the specific updates that have occurred
in the 3-month period along with a
hyperlink to the full listing that is
available on the CMS website or the
appropriate data registries that are used
as our resources. This is the most
current up-to-date information and will
be available earlier than we publish our
quarterly notice. We believe the website
list provides more timely access for
beneficiaries, providers, and suppliers.
We also believe the website offers a
more convenient tool for the public to
find the full list of qualified providers
for these specific services and offers
more flexibility and ‘‘real time’’
accessibility. In addition, many of the
websites have listservs; that is, the
public can subscribe and receive
immediate notification of any updates to
the website. These listservs avoid the
need to check the website, as
notification of updates is automatic and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
64493
sent to the subscriber as they occur. If
assessing a website proves to be
difficult, the contact person listed can
provide information.
III. How To Use the Notice
This notice is organized into 15
addenda so that a reader may access the
subjects published during the quarter
covered by the notice to determine
whether any are of particular interest.
We expect this notice to be used in
concert with previously published
notices. Those unfamiliar with a
description of our Medicare manuals
should view the manuals at https://
www.cms.gov/manuals.
The Director of the Office of Strategic
Operations and Regulatory Affairs of the
Centers for Medicare & Medicaid
Services (CMS), Kathleen Cantwell,
having reviewed and approved this
document, authorizes Trenesha FultzMimms, who is the Federal Register
Liaison, to electronically sign this
document for purposes of publication in
the Federal Register.
Dated: November 12, 2021.
Trenesha Fultz-Mimms,
Federal Register Liaison, Department of
Health and Human Services.
BILLING CODE 4120–01–P
E:\FR\FM\18NON1.SGM
18NON1
khammond on DSKJM1Z7X2PROD with NOTICES
Jkt 256001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4725
E:\FR\FM\18NON1.SGM
18NON1
How to Obtain Manuals
The Internet-only Manuals (IOMs) are a replica of the Agency's
official record copy. Paper-based manuals are CMS manuals that were
officially released in hardcopy. The majority of these manuals were
transferred into the Internet-only manual (IOM) or retired. Pub 15-1, Pub
15-2 and Pub 45 are exceptions to this rule and are still active paper-based
manuals. The remaining paper-based manuals are for reference purposes
only. If you notice policy contained in the paper-based manuals that was
not transferred to the IOM, send a message via the CMS Feedback tool.
Those wishing to subscribe to old versions of CMS manuals should
contact the National Technical Information Service, Department of
Commerce, 5301 Shawnee Road, Alexandria, VA 22312 Telephone
(703-605-6050). You can download copies of the listed material free of
charge at: https://cms.gov/manuals.
How to Review Transmittals or Program Memoranda
Those wishing to review tmnsmittals and progmm memomnda can
access this information at a local Federal Depository Library (FOL). Under
the FDL program, government publications are sent to approximately 1,400
designated libraries throughout the United States. Some FDLs may have
arrangements to transfer material to a local library not designated as an
FDL. Contact any library to locate the nearest FDL. This information is
available at https://www.gpo.gov/libraries/
In addition, individuals may contact regional depository libraries
that receive and retain at least one copy of most federal government
Fee-For Service Transmittal Numbers
Please Note: Beginning Friday, March 20, 2020, there will be the
following change regarding the Advance Notice of Instructions due to a
CMS internal process change. Fee-For Service Transmittal Numbers will
no longer be determined by Publication The Transmittal numbers will be
issued by a single numerical sequence beginning with Transmittal Number
10000.
For the purposes of this quarterly notice, we list only the specific
updates to the list of manual instructions that have occurred in the 3-month
period. This information is available on our website at
www.crns.gov/Manuals.
Transmittal
Number
Manual/Subject/Publication Number
10880
Internet Only Manual Updates to Pub. 100-01, 100-02, and 100-04 to
Implement Consolidated Appropriations Act Changes and Correct Errors and
Omissions (SNF)
10880
Internet Only Manual Updates to Pub. 100-01, 100-02, and 100-04 to
Implement Consolidated Appropriations Act Changes and Correct Errors and
Omissions (SNF)
10888
National Coverage Determination (NCD) Removal
Extra.corporeal Immunoadsorption (ECI) Using Protein A Columns
Electrosleep Therapy
Implantation of Gastrointestinal Reflux Devices
Abarelixfor the Treatment of Prostate Cancer
Magnetic Resonance Spectroscopy
Positron Emission Tomography (PET) Scans
FDG PET for Inflanunation and Infection
National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor
(CAR) T-cell Therapy- This CR Rescinds and Fullv Replaces CR 11783.
10891
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Addendum I: Medicare and Medicaid Manual Instrm.1ions
(July through September 2021)
The CMS Manual System is used by CMS program components,
partners, providers, contractors, Medicare Advantage organizations, and
State Survey Agencies to administer CMS programs. It offers day-to-day
operating instructions, policies, and procedures based on statutes and
regulations, guidelines, models, and directives. In 2003, we transformed the
CMS Program Manuals into a web user-friendly presentation and renamed
it the CMS Online Manual System.
publications, either in printed or microfilm form, for use by the general
public. These libraries provide reference services and interlibrary loans;
however, they are not sales outlets. Individuals may obtain information
about the location of the nearest regional depository library from any
library. CMS publication and transmittal numbers are shown in the listing
entitled Medicare and Medicaid Manual Instructions. To help FDLs locate
the materials, use the CMS publication and transmittal numbers. For
example, to find the manual for Quarterly Update for Clinical Laboratory
Fee Schedule (CLFS) and Laboratory Services Subject to Reasonable
Charge Payment, use (CMS-Pub. 100-04) Transmittal No. 10988.
Addendum I lists a unique CMS tnmsmittal number for each
instruction in our manuals or program memoranda and its subject number.
A transmittal may consist of a single or multiple instruction(s). Often, it is
necessary to use information in a transmittal in conjunction with
information currently in the manual.
64494
VerDate Sep<11>2014
EN18NO21.067
Publication Dates for the Previous Four Quarterly Notices
We publish this notice at the end of each quarter reflecting
information released by CMS during the previous quarter. The publication
dates of the previous four Quarterly Listing of Program Issuances notices
are: November 4, 2020 (85 FR 70168), March 17, 2021 (86 FR 14629),
May 3, 2021 (86 FR 23373) and August 17, 2021 (86 FR 45986. We are
providing only the specific updates that have occurred in the 3-month
period along with a hyperlink to the website to access this information and a
contact person for questions or additional information
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
10927
Jkt 256001
10985
10862
PO 00000
Frm 00051
Fmt 4703
Sfmt 4725
E:\FR\FM\18NON1.SGM
18NON1
10865
10872
EN18NO21.068
10878
10891
10898
10918
10919
10920
10929
10931
10932
10934
10935
10937
10940
10941
10942
10943
Changes to the Laboratory National Coverage Determination [NCD] Edit
Software for October 2021
Update to the Internet-only Manual (IOM) Publication (Pub.) 100-04,
Medicare Claims Processing Manual, Chapter 23 - Fee Schedule
Administration and Coding Requirements, Section 20.9 - Fee Schedule
Administration and Coding Requirements
Kational Correct Coding Initiative (NCC!)
Correct Coding Modifier Indicators (CCMI) and HCPCS Codes Modifiers
Instructions for Codes With Modifiers (A/B MACs (B) Only
Appeals
Procedure-to-Procedure (PTP) Edits
Medically Unlikely Edits (MUEs)
Kational Correct Coding Initiative (NCC!) Edits Ouarterlv Updates
National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor
(CAR) T-cell Therapy - This CR Rescinds and Fully Replaces CR 11783.
Chimeric Antigen Receptor (CAR) T-cell therapy
Coverage Requirements
Rilling Requirementq
A/B Medicare Administrative Contractor (MAC) (A) Bill Types
A/B MAC (A) Revenue Codes
A/B MAC Billing Healthcare Common Procedural Coding System (HCPCS)
Codes
A/B MAC Diagnosis Requirements
Payment Requirements
Claim Adjustment Reason Codes (CARCs), Remittance Advice Remark
Codes (RARCs), Group Codes, and Medicare Summary Notice (MS~)
Messages
Claims Editing
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Sensilivilv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Sensitivity of Instruction
Update to Hospice Payment Rates, Hospice Cap, Hospice Wage Index and
Hosoice Pricer for FY 2022
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentiality of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentiality of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Sensitivity of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentialitv of Instruction
Inpatient Rehabilitation Facility (IRF) Annual Update: Prospective Payment
System (PPS) Pricer Changes for FY 2022
64495
10875
10876
Section 50 in Chapter 30 of Publication (Pub.) 100-04 Manual Updates
Section 50 in Chapter 30 of Publication (Pub.) 100-04 Manual Updates
Advance Beneficiary Notice of Kon-coverage (ABN
AI3N Scope
ABN Uses
Optional AHN Uses
Issuance of the ABN
Triggering Events
ABN Standards
Completing the ABN
Retention Requirements
ABN Delivery Requirements
Options for Delivery Other than In-Person
Effects of Lack of Notification, Medicare Review and Claim Adjudication
Using ABNs for Medical Equipment and Supplies Claims When Denials
Under §1814(a)(17)(R) of the Act (Prohibition Against Unsolicited Telephone
Contacts) Are Expected
ABNs for Medical Equipment and Supplies Claims Denied Under §1834(j)(l)
oflhe Ad (Because lhe Supplier Did Nol Meet Supplier Number
Requirements)
ABNs for Claims Denied in Advance Under §1834(a)(15) of the Act
ABN Standards for Upgraded Durable Medical Equipment, Prosthetics,
Orthotics, and Supplies (DMEPOS)
ABNs for items listed in a DMEPOS Competitive Bidding Program (CBP)
/Collection ofF1111ds and Refunds
Physicians' Services
DMEPOS RR Provision for Claims for Medical Equipment and Supplies
Time Limits and Penalties for Healthcare Providers and Suppliers in Making
Refunds
Supplier's Right to Recover Resalable Items for Which Refund Has Been
Made
CMS Regional Office (RO) Referral Procedures
ABN Special Considerations
Glossary
July Quarterly Update for 2021 Durable Medical Equipment, Prosthetics,
Orthotics and Supplies (DMEPOS) Fee Schedule
Annual Updates to the Prior Authorization/Pre-Claim Review Federal
Holidav Schedule Tables for Generating Reports
Instructions for Downloading lhe Medicare ZIP Code Files for October 2021
Issued to a specific audience, not posted to Internet/Intranet due to a
Sensitivitv oflnstruction
10877
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
10981
Chimeric Antigen Receptor (CAR) T-cell therapy_
National Coverage Determination (NCD) Removal
Extracorporeal Imm1111oadsorption (ECI) Using Protein A Colunms
Electrosleep Therapy
Implantation of Gastrointestinal Reflux Devices
Abarclix for the Treatment of Prostate Cancer
Magnetic Resonance Spectroscopy
Positron Emission Tomography (PET) Scans
FDG PET for Inflammation and Infection
National Coverage Determination (NCD) 270.3 Blood-Derived Products for
Chronic, Non-Healing Wounds
Blood-Derived Products for Chronic. Non-Healing Wo1111ds
Claims Processing Instructions for National Coverage Determination 20.33 "tation
Transcatheter Edge-to-Edge Reoair fTEERl for Mitra! Valve Re
khammond on DSKJM1Z7X2PROD with NOTICES
10947
10959
10961
Jkt 256001
10962
10964
10965
PO 00000
10966
10967
Frm 00052
Fmt 4703
10968
10969
Sfmt 4725
10970
10971
E:\FR\FM\18NON1.SGM
10972
10979
10981
18NON1
10983
EN18NO21.069
10985
10987
10988
10991
10992
10996
10997
11000
10873
10921
10939
10887
10982
Claims Processing Instructions for National Coverage Determination 20.33 Transcatheter Edge-to-Edge Repair [TEER] for Mitral Valve Regurgitation
Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation
Coding Requirements for Mitral Valve TEER Claims Furnished on or After
August 7, 2014
Claims Processing Requirements for Mitra! Valve TEER Services on
Professional Claims
Home Health Notices of Admission -- Additional Manual Instructions
Submission of the Notice of Admission (NOA) HH PPS Claims
Quarterly Update for Clinical Laboratory Fee Schedule (CLFS) and
Laboratorv Services Subiect to Reasonable Charge Payment
Instructions for Retrieving the January 2022 Medicare Physician Fee
Schedule Database (MPFSDB) Files Through the CMS Mainframe
Telecommunications Svstem
Onarterlv Update to Home Health (HH) Grouper
October 2021 Integrated Outpatient Code Editor (L'OCE) Specifications
Version 22.3
October 2021 Update of the Hospital Outpatient Prospective Payment System
COPPS)
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentiality of Instruction
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentiality of Instruction
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentiality of Instruction
Notice of New Interest Rate for Medicare Overpayments and Underpayments
- 4th Otr Notification for FY 2021
Issued to a specific audience, not posted to Internet/Intranet due to a
Confidentiality of Instruction
None
10849
10867
10868
Revising Subsection 3.5.4, Tracking Medicare Contractors' Prepayment and
Postpayment Reviews, in Chapter 3 of Publication (Pub.) 100-08 Tracking
Medicare Contractors' Prepayment and Postpayment Reviews
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentialitv of Instruction
Third General Update to Chapter 10 of Publication (Pub.) 100-08 Third
General Update lo Chapter 10 of Publication (Pub.) 100-08 Certified
Providers and Certified Suppliers That Enroll Via the Form CMS- 855A
Community Mental Health Centers (CMHCs
Comprehensive Outpatient Rehabilitation Facilities (CORFs)
End-Stage Renal Disease Facilities (ESRDs)
Federally Qualified Health Centers (FQHCs)
Histocompatibility Laboratories
Home Health Agencies (HHAs
Hospices
Hospitals and Hospital Units
Indian Health Services (!HS) Facilities
Organ Procurement Organizations (OPOs)
Outpatient Physical Therapy/Outpatient Speech Pathology Services
(OPT/OSP)
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
10950
Inpatient Psychiatric Facilities Prospective Payment System (!PF PPS)
Updates for Fiscal Year (FY) 2022
Annual Update
Cost-of-Living Adiustment (COLA) for Alaska and Hawaii
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentialitv of Instruction
File Conversions Related lo the Spanish Translation of the Healthcare
Common Procedure Coding Svstem (HCPCS) Descriptions
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentialitv of Instruction
Issued to a specific audience, not posted to hrternet/Intranet due to a
Confidentialitv of Instruction
Issued lo a specific audience, not posted lo lnlernel/Intranel due lo a
Confidentialitv of Instruction
Combined Common Edits/Enhancements Modules (CCEM) Code Set Update
Issued to a specific audience, not posted to hrternet/Intranet due to a
Sensitivitv of Instruction
Issued to a specific audience, not posted to hrternet/Intranet due to a
Sensilivilv oflnslruclion
Implement Operating Rules - Phase Ill Electronic Remittance Advice (ERA)
Electronic Funds Transfer (EFT): Committee on Operating Rules for
Information Exchange (CORE) 360 Uniform Use of Claim Adjustment
Reason Codes (CARC), Remittance Advice Remark Codes (RARC) and
Claim Adjustment Group Code (CAGC) Rule - Update from Council for
Affordable Quality Healthcare (CAQII) CORE
Issued to a specific audience, not posted to hrternet/Intranet due to a
Sensitivity of Instruction
Quarterly Update to the Medicare Physician Fee Schedule Database
(MPFSDB) - October 2021 Update
Shared System Support Hours for Application Prograrmning Interfaces (APis)
2022 Annual Update for the Health Professional Shortage Area (HPSA)
Bonus Payments
January 2022 Healthcare Common Procedure Coding System (HCPCS)
Quarterly Update Reminder Clotting Factor Furnishing Fee
Instructions for Retrie"ing the January 2022 Opioid Treatment Program
(OTP) Payment Rates Through the CMS Mainframe Telecommunications
Svstem
National Coverage Determination (NCD) 270.3 Blood-Derived Products for
Chronic, Non-Healing Wounds
Autologous Platelet-Rich Plasma (PRP) for Chronic Non-Healing Wounds
Policy
Healthcare Common Procedure Coding System (HCPCS) Codes, Diagnosis
Coding and Frequency Requirements
Types of Dill (TOD)
Payment Method
Place of Service (POS) for Professional Claims
Medicare Summary Notices (MSNs), Remittance Advice Remark Codes
(RCs), Claim Adiustment Reason Codes (CARCs) and Group Codes
Influenza Vaccine Payment Allowances - Annual Update for 2021-2022
Season
64496
VerDate Sep<11>2014
10944
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
Jkt 256001
PO 00000
10882
10893
Frm 00053
10909
Fmt 4703
10910
Sfmt 4725
E:\FR\FM\18NON1.SGM
10911
10913
10926
10945
18NON1
10958
10975
10976
10984
1900
Updates to Pub. 100-09, Chapter 6 Beneficiary and Provider
Communications Manual, Chapter 6, Provider Customer Service Program
Note
Introduction to Provider Customer Service Program
PCSP Electronic Mailing Lists
PCUGCall
Integration of POE, PCC, and PSS Activities in the PCSP
Partners in Progress Meeting
Provider Outreach and Education
Partnering with External Entities and with Other MACs
Analysis of Claims Submission Errors
Provider Bulletins/Newsletters
Direct Mailings for the PCSP
Training Tailored for Small Medicare Providers
Remittance Advice (RA)
POE Advisory Groups (POE AGs
Ask-the-Contractor Teleconferences
POE Reporting
Provider Service Plan (PSP)
Provider Customer Service Program Activity Report (PAR)
Discretionary Reporting
Charging Fees to Providers for Medicare Education and Training
Reimbursement from Providers for POE Staff Attendance at Provider
Meetings
Refunds/Credits for Cancellation of Education and Training Activities
Provider Contact Center (PCC)
Pre-Approved PCC Closures
Emergency and Similar PCC Closures
Inquiry Triage Process
Responding to Coding Questions
Provider Telephone Inquiries
Provider Inquiries Line
Troubleshooting PCC Service Interruptions
Requesting Changes to Telephone Configurations
Hours of Operation
Providing Busy Signals
64497
EN18NO21.070
10994
Organizational Requirements
liability of Program Integrity Contractor Employees
Anti-Fraud Training
Procedural Requirements
MAC Complaint Screening
Referrals to the UPIC
Home Health Agency Misuse of Requests for Anticipated Payments
RAP Monitoring
Education and Additional Monitoring
Corrective Action Plans
Kotification to the HHA
CAP Submission
CAP Acceptance and Monitoring
CAP Closeout
Suppression
Kotice of RAP Suppression
Monitoring During RAP Suppression
Result of Initial RAP Suooression Monitoring Period
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentiality of Instructions
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
10879
Religious Kon-Medical Health Care Institutions (RNHCis)
Rural Health Clinics (RHCs)
Skilled Nursing Facilities (SNFs)
Miscellaneous Policies
Other Enrollment Forms: Information and Processing
Form CMS-588 - Electronic Funds Transfer (EFT) Authorization
Agreement
Form CMS-460 - Medicare Participating Physician or Supplier Agreement
Provider and Supplier Business Structures
Owning and Managing Information
Organizational Owning and Managing Information
Individual Owning and Managing Information
Owning and Managing Information - Tax Identification Numbers (TINs)
Billing Agencies
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentiality of Instructions
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentialitv of Instructions
Revision to Medicare Administrative Contractor (MAC) Complaint Screening
Process - Checking the Recovery Audit Contractor (RAC) Data Warehouse
(RACDW) Prior to Claim Adiustment Complaint Screening Process
Fourth General Update to Chapter 10 of Publication (Pub.) 100-08
Opioid Treatment Programs
Opting-Out of Medicare
Application Fees
Screening: On-Site Inspections and Site Verifications
Miscellaneous Enrollment Topics
Updates lo Exhibit 16 in Exhibits Chapter of Publication (Pub.) 100-08
Model Payment Suspension Letters
Opioid Treatment Programs
Opting-Out of Medicare
Application Fees
Screening: On-Site Inspections and Site Verifications
Miscellaneous Enrollment Topic
Issued lo a specific audience, not posted lo Internet/Intranet due lo
Confidentiality of Instructions
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentialitv of Instructions
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentiality of Instructions
Removal of Provider Enrollment Policy from Chapter 15 in Publication (Pub.)
100-08
Issued to a specific audience, not posted to InterneVIntranet due to
Confidentialitv of Instructions
Changes of Information Involving Certified Providers and Certified Suppliers
Issued to a specific audience, not posted to IntcrncVIntranct due to
Confidentialitv of Instructions
Updates to Chapters 1, 3, 4, 5, 8 and 9 of Publication (Pub.) 100-08
Quality of Care Issues and Potential Fraud Issues
Provider Self Audits
Signature Requirement~
Introduction
Pro gram Intc grity
Program Integrity Contractors
Cnified Program Integrity Contractor
Investigations Medicare Drug Inte!!ritv Contractor
khammond on DSKJM1Z7X2PROD with NOTICES
Jkt 256001
None
None
PO 00000
None
None
Frm 00054
None
None
Fmt 4703
10889
10894
Sfmt 4725
10924
10936
E:\FR\FM\18NON1.SGM
10938
10949
10956
10960
10974
18NON1
10978
10993
10848
10852
10856
10861
10863
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
of Instructions
Modifications/Improvements to Value-Based Insurance Design (VBID)
Model Implementation
Issued lo a specific audience, nol posted lo lnlerne1/Inlranel due lo Sensitivity
of Instructions
Federally Qualified Health Center (FQHC) Participation in and Payment
Under the Marvland Primarv Care Program (MDPCP) - Implementation
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
of Instructions
Issued lo a specific audience, nol posted lo lnlerne1/Inlranel due lo Sensitivity
of Instructions
Issued to a specific audience, not posted to Internet/Intranet due to
Confidentiality of Instructions
Managing Clinician PPA and KCF PBA Implementation
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
oflnslructions
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
of Instructions
Kidney Care Choices (KCC) Kidney Care First (KCF) - Payment Mechanism
(PM) and Benefit Enhancements (BEs) - Imolementation
Issued to a specific audience, not posted to Internet/Intranet due to
Confidentiality of Instructions
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
oflnstructions
Implementation of the Award for the Jurisdiction E (J-E) Part A and Part B
Medicare Administrative Contractor (JE A/B MAC)
Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS)
Prior Authorization Coversheet Requirements
User CR: MCS - Beneficiarv Do Not Forward DLV Flag Changes Needed
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
10930
Inquiry Tracking Data to be Reported in PCID
PCC Training Closure Information to be Reported in PCIU
Provider Electronic Mailing List Subscriber Data to be Reported in PCID
Special Initiatives to be Reported in PCID
Emergency and Similar PCC Closure Data to be Reported in PCID
Telecommunications Service Interruptions to be Reported in PCID
QCM
QWCM
Disclosure of Information
Issued to a specific audience, not posted to Internet/Intranet due to
Confidentiality of Instructions
64498
VerDate Sep<11>2014
EN18NO21.071
Provider Telephone Line Staffmg
Quality Call Monitoring
Quality Assurance Monitoring (QAM
Remote Monitoring
Telephone Responses to Provider Inquiries - QWCM Program Minimum
Requirements
Recording Calls
QCM Calibration
Provider Written Inquiries
Telephone Responses to Provider Written Inquiries
Electronic Responses to Provider Written Inquiries
Guidelines for High Quality Responses to Provider Written Inquiries
Stock Language/Form Letters
QWCM Calibration
PRRS Operations
Complex Provider Inquiries
Complex Beneficiary Inquiries
Provider Inquiry Tracking
Updates to the CMS Standardized Provider Inquiry Chart
MAC Inquiry Tracking Self-Data Review and Self-Validation Process
Fraud and Abuse
PCSP Staff Development and Education
PCC Staff Development and Training
Required Training for PCC Staff
PCC Training Program
PCC Training Documentation
Provider Self-Service (PSS) Technology
Interactive Voice Response(IVR) System
Provider Education Website
General Requirements
W ebmaster and Attestation Requirements
Website Governance
CMS Feedback
Contents
Dissemination of Information from CMS to Providers
Web-based Provider Educational Offerings
Provider Claims Payment Alerts
Electronic Mailing List
Targeted Electronic Mailing Lists
Electronic Mailing List Promotion
Social Media
Internet-based Provider Portal Service Interruptions
Surveys
Provider Satisfaction Survey
MAC Survey Participation Requirements
Closed-Loop Ticketing
MAC Satisfaction Score
Performance Management
Electronic Mailing List Subscribership
Call Completion
Average Speed of Answer (ASA)
Callbacks
PCSP Data Reporting
PIES
Due Date for Data Submission to PIES
MAC Contract and PCSP Data to be Reported in PCID
Additional Data to be Reported Monthly in PCID and Reporting Due Dates
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
10890
10895
10896
10928
Jkt 256001
10933
PO 00000
10948
10951
Frm 00055
10953
10954
10955
Fmt 4703
10957
Sfmt 4725
10963
E:\FR\FM\18NON1.SGM
10977
10986
10989
10990
18NON1
10340
10980
Issued to a specific audience, not posted to Internet/Intranet due to
Confidentialitv of Instructions
Issued to a specific audience, not posted to Internet/Intranet due to
Confidentialitv of Instructions
None
None
EN18NO21.072
For questions or additional information, contact Terri Plumb
(410-786-4481).
Addendum ID: CMS Rulings
(July through September 2021)
CMS Rulings are decisions of the Administrator that serve as
precedent final opinions and orders and statements of policy and
interpretation They provide clarification and interpretation of complex or
ambiguous provisions of the law or regulations relating to Medicare,
Medicaid, Utilization and Quality Control Peer Review, private health
insurance, and related matters.
The rulings can be accessed at https://www.cms.gov/Regulationsand-Guidance/Guidance/Rulings. For questions or additional information,
contact Tiffany Lafferty (410-786-7548).
Addendum IV: Medicare National Coverage Determinations
(July through September 2021)
Addendum IV includes completed national coverage
determinations (NCDs), or reconsiderations of completed NCDs, from the
quarter covered by this notice. Completed decisions are identified by the
section of the NCD Manual (NCDM) in which the decision appears, the
title, the date the publication was issued, and the effective date of the
decision. An NCD is a determination by the Secretary for whether or not a
particular item or service is covered nationally under the Medicare Program
(title XVIII of the Act), but does not include a determination of the code, if
any, that is assigned to a particular covered item or service, or payment
determination for a particular covered item or service. The entries below
include information concerning completed decisions, as well as sections on
program and decision memoranda, which also announce decisions or, in
some cases, explain why it was not appropriate to issue an NCD.
Information on completed decisions as well as pending decisions has also
64499
Addendum II: Regulation Documents Published
in the Federal Register (July through September 2021)
Regulations and Notices
Regulations and notices are published in the daily Federal
Register. To purchase individual copies or subscribe to the Federal
Register, contact GPO at www.gpo.gov/fdsys. When ordering individual
copies, it is necessary to cite either the date of publication or the volume
number and page number.
The Federal Register is available as an online database through
GPO Access. The online database is updated by 6 a.m. each day the
Federal Register is published. The database includes both text and
graphics from Volume 59, Number 1 (January 2, 1994) through the present
date and can be accessed at https://www.gpoaccess.gov/fr/. The
following website https://www.archives.gov/federal-register/ provides
information on how to access electronic editions, printed editions, and
reference copies.
This information is available on our website at:
https://www.cms.gov/fi1es/document/regs3q21qpu.pdf
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
10899
Replacing Home Health Requests for Anticipated Payment (RAPs) with a
Notice of Admission
J<'acility
Provider
Number
J<:tlecti.ve Date
State
Banner Del Webb Medical Center
14502 W. Meeker Boulevard
Sun Citv West AZ 85375
Orlando Health - Health Central
Hospital
1222 S. Orange Avenue MP 856.
Orlando, FL 32806
WakeMed Cary Hospital
1900 Kildaire Farm Road
Carv, NC 27518
Community Hospital South
1402 East County Line
Indianaoolis, IN 46227
Huntsville Health System - Marshall,
431 Highway
North Boaz, AL 35957
Sutter Roseville Medical Center
One Medical Plaza
Roseville, CA 95661
030093
06/29/2021
AZ
1184709057
06/29/2021
FL
340173
04/05/2021
NC
150128
09/07/2021
IN
0l0005
09/21/2021
AL
050309
09/28/2021
CA
300029
06/01/2005
NH
150173
07/02/2009
TN
050007
l0/11/2005
CA
FROM: Portsmouth Regional
Hospital
TO: HCA Healthcare Services of
New Hampshire, Inc.
333 Borthwick Avenue
Portsmouth, NH 03801
FROM: Clarian Arnett Health
TO: Indiana University Health
Arnett
5165 McCarty Lane
Lafavette IN 47905
FROM: Mills Peninsula Health
Services
TO: Mills Peninsula Medical Center
FROM: 1783 El Camino Real
TO: 1501 Trousdale Drive
Burlingame, CA 94010
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Title
only if performed in facilities that have been determined to be competent in
performing the evaluation, procedure, and follow-up necessary to ensure
optimal patient outcomes. We have created a list of minimum standards for
facilities modeled in part on professional society statements on competency.
All facilities must at least meet our standards in order to receive coverage
for carotid artery stenting for high risk patients. For the purposes of this
quarterly notice, we are providing only the specific updates that have
occurred in Ure 3-monU1 period. This infonnation is available at:
https://wvvw.cms.gov/MedicareApprovedFacilitie/CASF/list.asp#TopOfPage
For questions or additional information, contact Sarah Fulton, MHS
(410-786-2749).
64500
VerDate Sep<11>2014
been posted on the CMS website. For the purposes of this quarterly notice,
we are providing only the specific updates to national coverage
detenninations (NCDs), or reconsiderations of completed NCDs published
in the 3-month period. This information is available at:
www.cms.gov/medicare-coverage-database/. For questions or additional
information, contact Wanda Belle, MPA (410-786-7491).
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
Facility
Jkt 256001
PO 00000
St. Lucie Medical Center
1800 SE Tiffany Avenue
Port St. Lucie, FL 34952
Effective Date
State
05/26/2005
UT
450530
10/20/2006
TX
10-0260
08/19/2021
FL
Frm 00057
Fmt 4703
Sfmt 4725
Addendum VIII:
American College of Cardiology's National Cardiovascular Data
Registry Sites (July through September 2021)
The initial data collection requirement through the American
College of Cardiology's National Cardiovascular Data Registiy (ACCNCDR) has setVed to develop and improve the evidence base for the use of
I CDs in certain Medicare beneficiaries. The data collection requirement
ended with the posting of the final decision memo for Implantable
Cardioverter Defibrillators on February 15, 2018.
For questions or additional infonnation, contact Sarah Fulton,
MHS (410-786-2749).
E:\FR\FM\18NON1.SGM
Addendum IX: Active CMS Coverage-Related Guidance Documents
18NON1
AddendumX:
EN18NO21.074
Addendum XI: National Oncologic PET Registry (NOPR)
(July through September 2021)
Addendum XI includes a listing of National Oncologic Positron
Emission Tomography Registry (NOPR) sites. We cover positron emission
tomography (PET) scans for particular oncologic indications when they are
performed in a facility that participates in the NOPR.
In January 2005, we issued our decision memorandum on positron
emission tomography (PET) scans, which stated that CMS would cover
PET scans for particular oncologic indications, as long as they were
performed in the context of a clinical study. We have since recognized the
National Oncologic PET Registiy as one of these clinical studies.
Therefore, in order for a beneficiary to receive a Medicare-covered PET
scan, the beneficiary must receive the scan in a facility that participates in
the registiy. There were no additions, deletions, or editorial changes to the
listing of National Oncologic Positron Emission Tomography Registry
(NOPR) in the 3-month period. This infonnation is available at
https://www.cms.gov/MedicareApprovedFacilitie/NOPR/list.asp#TopOfPage.
For questions or additional infonnation, contact David Dolan, MBA (410786-3365).
Addendum XII: Medicare-Approved Ventricular Assist Device
(Destination Therapy) Facilities (July through September 2021)
Addendum XII includes a listing of Medicare-approved facilities
that receive coverage for ventricular assist devices (VADs) used as
destination therapy. All facilities were required to meet our standards in
order to receive coverage for V ADs implanted as destination therapy. On
October 1, 2003, we issued our decision memorandum on V ADs for the
clinical indication of destination therapy. We determined that V ADs used
as destination therapy are reasonable and necessary only if performed in
facilities that have been determined to have the experience and
infrastructure to ensure optimal patient outcomes. We established facility
standards and an application process. All facilities were required to meet
our standards in order to receive coverage for V ADs implanted as
destination therapy.
For the pmposes of this quarterly notice, we are providing only the
specific updates to the list of Medicare-approved facilities that meet our
standards that have occurred in the 3-month period. This infonnation is
available at
64501
(July through September 2021)
CMS issued a guidance document on November 20, 2014 titled
"Guidance for the Public, Indusuy, and CMS Staff: Coverage with
Evidence Development Document". Although CMS has several policy
vehicles relating to evidence development activities including the
investigational device exemption (IDE), the clinical trial policy, national
coverage determinations and local coverage determinations, this guidance
document is principally intended to help the public understand CMS' s
implementation of coverage with evidence development (CED) through the
national coverage determination process. The document is available at
https://www.ems.gov/medicare-coverage-database/details/medicarecoverage-document-details.aspx?MCDid=27. There are no additional
Active CMS Coverage-Related Guidance Documents for the 3-month
period. For questions or additional infonnation, contact
JoAnna Baldwin, MS (410-786-7205).
List of Special One-Time Notices Regarding National Coverage
Provisions (July through September 2021)
There were no special one-time notices regarding national
coverage provisions published in the 3-month period. This infonnation is
available at https://www.cms.gov . For questions or additional infonnation,
contact JoAnna Baldwin, MS (410-786 7205).
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
FROM: Utah Valley Regional
Medical Center
TO: IHC Health Services, Inc. dba
Utah Valley Hospital
1034 N 500 West
Provo UT 84604
FROM: Mainland Medical Center
TO: HCA Houston Healthcare
Mainland Campus
6801 Emmett F. Lowry Expressway
Texas City, TX 77591
Provider
Number
460001
khammond on DSKJM1Z7X2PROD with NOTICES
(410-786-3365).
Jkt 256001
Provider
Number
Date of Initial
Certification
Daylor Scott & White
All Saints Medical Center Fort Worth
1400 8th Avenue
Port Worth, TX 76104
450137
05/26/2021
State
TX
PO 00000
Frm 00058
Previous Re-certification
Dates: n/a
AU Medical Center
1120 15th Street
Augusta, GA 30912
Fmt 4703
Sfmt 4725
Previous Re-certification
Dates: n/a
110034
"'
E:\FR\FM\18NON1.SGM
TO: Adventist Health
System/Sunbelt Inc. dba
Florida Hospital
FROM Adventist Health
System/Sunbelt Inc. dba
Advent Health
601 East Rollins Street
Orlando, FL 32803
08/06/2021
GA
;
100007
10/24/2012
06/12/2021
FL
18NON1
Joint Commission ID # 6584
Previous Re-certification
Dates:
Date of Recertification
State
460009
01/13/2009
05/21/2021
UT
Certificate#: 10000435189MSC-DNV GL-USA
Previous Re-certification
Dates:
01/13/2009; 07/13/2011;
06/18/2013; 06/23/2015;
08/08/2017; 05/25/2018
Medical City Dallas
7777 Forest Lane
Dallas, TX 75230
450647
09/09/2008
04/03/2021
TX
Other information:
Joint Commission ID # 9008
Previous Re-certification
Dates:
09/09/2008; 08/10/2010;
07/17/2012; 06/27/2014;
07/12/2016
Vauderbilt University Medical
Center
1211 Medical Center Drive
Na~hville, TN 37232-2101
440039
04/2012012
04/28/2021
TN
100038
08/20/2014
03/27/2021
FL
340091
01/07/2014
04/17/2021
NC
Joint Commission ID # 7892
Previous Re-certification
Dates:
04/20/2012; 03/11/2014;
04/05/2016- 05/08/2018
Memorial Regional Hospital
350 I Johnson Street
Hollywood, FL 33021
Other infonnation:
Joint Commission ID # 6873
Previous Re-~erlificalion
Dates:
10/24/2012: 10/07/2014;
11/15/2016; 01/30/2019
Medical University of South
Carolina Medical Center
169 Ashley Avenue
Charleston, SC 29425
Date of Initial
Certification
Other information:
Other information:
DNV GL# 10000469761Assessment Services-DNV
GL-USA
Other information
DNV ID # 10000483076MSC-DNV-USA
EN18NO21.075
DateofRecertification
09/23/2010; 09/07/2012;
08/05/2014; 09/13/2016;
09/26/2018
University of Utah, Hospitals
and Clinics
50 N. Medical Drive
Salt Lake City, UT 84132
Provider
Number
Joint Commission ID# 6811
420004
09/23/2010
03/24/2021
WI
Previous Re-certification
Dates: 2016-08-11; 2014-08-20
Moses H. Cone Memorial
Hospital
1200 North Elm Street
Greensboro, NC 27401-1020
Other information:
Joint Commission ID # 6504
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Facility
Facility
64502
VerDate Sep<11>2014
https://www.cms.gov/MedicareApprovedFacilitieNAD/list.asp#TopOfPage.
For questions or additional information, contact David Dolan, MBA,
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
Facility
DateofRccertification
State
Jkt 256001
PO 00000
Frm 00059
Previous Re-certification
Dates: 2010-06-08; 2012-0525; 2014-04-15; 2016-06-15;
2018-07-18
University of Iowa Hospitals
and Clinics
200 Hawkins Drive
Iowa City, IA 52242
390111
06/08/2010
05/06/2021
PA
160058
06/22/2010
04/08/2021
IA
Fmt 4703
Sfmt 4725
09/14/2010
05/05/2021
IN
E:\FR\FM\18NON1.SGM
18NON1
Previous Re-certification
Dates:
09/14/2010; 10/24/2012;
10/21/2014; 11/01/2016
Emory Saint Joseph's Hospital
of Atlanta, Inc.
5665 Peachtree Dunwoody
Road
Atlanta, GA 30342
07/13/2010
05/08/2021
CA
380004
12/06/2011
07/24/2021
OR
250001
08/16/2016
05/20/2021
MS
450193
10/2812003
06/05/2021
TX
360003
12/13/2011
05/19/2021
OH
State
GA
Other information:
Joint Commission ID # 9098
Previous Re-certification
Dates:
10/07/2008; 11/17/2010;
11/06/2012;
University of Cincinnati
Medical Center, LLC
234 Goodman Street
Cincinnati, OH 45219
Other information:
Joint Commission ID # 6988
64503
Previous Re-certification
Dates:
07/13/2010; 07/11/2012;
06/03/2014; 07/12/2016;
06/05/2018
110082
Date of Recertification
04/14//2021
Other information:
Joint Commission ID # 8064
Previous Re-certification
Dates:
08/16/2016; 08/08/2018
CHI SL Luke's Health Baylor
College of Medicine Medical
Ctr
6720 Bertner Avenue
Houston, TX 77030
Other information:
Joint Commission ID# 7157
Date of Initial
Certification
02/11/2014
Other information:
Joint Commission ID# 9705
Previous Re-certification
Dates:
12/06/2011; 12/10/2013;
01/26/2016; 02/13/2018
University of Mississippi
Medical Center
2500 North State Street
Jackson, MS 39216
150017
Provider
Number
050017
Other information:
Joint Commission ID# 10053
Previous Re-certification
Dates:
02/11/2014; 03/08/2016;
03/13/2018
Providence St. Vincent
Medical Center
9205 SW Barnes Road
Portland, OR 97225
Joint Commission ID # 8266
Previous Re-certification
Dates:
06/22/201 O; 07/26/2012;
07/29/2014; 08/02/2016;
7/11/2018
Lutheran Hospital of Indiana
7950 West Jefferson Boulevard
For! Wayne, IN 46804
Facility
Mercy General Hospital
4001 J Street
Sacramento, CA 95819
Other infonnation:
Joint Commission ID# 6129
Other information:
Joint Commission ID # 6652
EN18NO21.076
Date of Initial
Certification
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Previous Re-certification
Dates:
01/07/2014; 02/09/2016;
02/13/2018
Hospital of the University of
Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Provider
Number
khammond on DSKJM1Z7X2PROD with NOTICES
08/12/2008
DateofRccertification
05/29/2021
State
Facility
IN
Previous Re-certification
Dates:
08/12/2008; 07/20/2010;
07/24/2012; 07/08/2014;
08/23/2016
Catholic Health Initiatives Iowa, Corp.
11 ll 6th A venue
Des Moines, IA 50314
Jkt 256001
PO 00000
Frm 00060
Fmt 4703
Previous Re-certification
Dates:
08/12/2008; 08/17/2010;
08/17/2012; 08/19/2014;
10/04/2016
University of Wisconsin
Hospitals and Clinics
Authority
600 Highland Avenue
Madison, WI 53792
520098
08/05/2008
06/04/2021
WI
Sfmt 4725
E:\FR\FM\18NON1.SGM
050327
02/07/2012
05/15/2021
CA
18NON1
Other infonnation:
Joint Commission ID # 9898
Previous Re-~erlificalion
Dates:
02/07/2012; 01/23/2014;
02/23/2016; 04/10/2018
INTEGRIS Baptist Medical
Center
3300 Northwest Expressway
Oklahoma City, OK 73112
Previous Re-certification
Dates:
10/23/2008; 10/01/2010;
10/03/2012; 09/23/2014;
11/08/2016- 12/5/2018
Tufts Medical Center
800 Wa.~hington Street
Boston, MA 02111
Other information:
Joint Commission TD# 5518
Previous Re-certification
Dates:
10/23/2008; 10/01/2010;
10/03/2012; 09/23/2014;
11/08/2016; 12/5/2018
Brigham and Women's
Hospital
75 Francis Street
Boston, MA 02115
Other infonnation:
Joint Commission ID# 7656
Previous Re-certification
Dates:
08/05/2008: 08/24/2010;
08/07/2012; 07/17/2014;
08/09/2016
Loma Linda University
Medical Center
11234 Anderson Street
Loma Linda, CA 92354
Provider
Number
Date of Initial
Certification
Date of Recertification
State
160083
01/06/2015
07/01/2021
IA
220116
10/23/2008
06/23/2021
MA
220ll0
11/0412008
07/10/2021
MA
200009
11/05/2008
07/08/2021
ME
Other information:
Joint Commission ID# 5518
Other information:
Joint Commission ID# 188549
Other information:
Joint Commission ID # 8872
EN18NO21.077
150056
Date of Initial
Certification
370028
08/12/2008
06/19/2021
OK
Other information:
Joint Commission ID# 5503
Previous Re-certification
Dates:
11/04/2008; 12/09/2010;
12/07/2012; 11/07/2014;
12/13/2016- 2/27/2019
FROM: Mame Medical
Center
TO: MameHealth
22 Bramhall Street
Portland, ME 04102
Other information:
Joint Commission ID# 5445
Previous Re-certification
Dates:
11/05/2008; 09/27/2016;
10/3/2018
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Previous Re-certification
Dates:
12/13/2011; 01/07/2014;
02/23/2016: 03/13/2018
FROM: Old: Indiana
University Health Methodist
Hospital
TO: Indiana University
Health, Inc.
1701 North Senate Boulevard
Indianapolis, IN 46202
Provider
Number
64504
VerDate Sep<11>2014
Facility
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
Facility
Sharp Memorial Hospital
7901 Frost Street
San Diego, CA 92123
Date of Initial
Certification
07/17/2008
Date of Recertification
06/05/2021
State
CA
360085
08/28/2021
OH
Previous Re-certification Dates:
12/15/2018
Tannnie Hayes, Director, LVRS,
614-293-3629
Jkt 256001
330106
09/27/2016
06/26/2021
NY
PO 00000
Frm 00061
Other information:
Joint conunission ID# 2091
Previous Re-certification
Dates:
09/27/2016; 9119/2018
Fmt 4703
Sfmt 4725
E:\FR\FM\18NON1.SGM
18NON1
Addendum XIII: Lung Volume Reduction Surgery (LVRS)
(July through September 2021)
Addendum XIII includes a listing of Medicare-approved facilities
that are eligible to receive coverage for lung volume reduction surgery.
Until May 17, 2007, facilities that participated in the National Emphysema
Treatment Trial were also eligible to receive coverage. The following three
types of facilities are eligible for reimbursement for Lung Volume
Reduction Surgery (LVRS):
• National Emphysema Treatment Trial (NETT) approved (Beginning
05/07/2007, these will no longer automatically qualify and can qualify only
with the other programs);
• Credentialed by the Joint Commission (formerly, the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO)) under
their Disease Specific Certification Program for LVRS; and
• Medicare approved for lung transplants.
Only the first two types are in the list. There was an update to the
listing of facilities for lung volume reduction surgery published in the
3-month period. This information is available at
www .cms.gov/MedicareApproved.Facilitie/LVRS/list.asp#TopOfPage. For
questions or additional information, contact Sarah Fulton, MHS
(410-786-2749).
Certification
Date
State
Addendum XV: FDG-PET for Dementia and Neurodegenerative
Diseases Clinical Trials (July through September 2021)
There were no FDG-PET for Dementia and Neurodegenerative
Diseases Clinical Trials published in the 3-month period.
This information is available on our website at
www.cms.gov/MedicareApprovedFacilitie/PETDT/list.asp#TopOfPage.
For questions or additional information, contact David Dolan, MBA (410786-3365).
64505
Provider#
Addendum XIV: Medicare-Approved Bariatric Surgery Facilities
(July through September 2021)
Addendum XIV includes a listing of Medicare-approved facilities
that meet minimum standards for facilities modeled in part on professional
society statements on competency. All facilities must meet our standards in
order to receive coverage for bariatric surgery procedures. On February 21,
2006, we issued our decision memorandum on bariatric surgery procedures.
We detennined that bariatric surgical procedures are reasonable and
necessary for Medicare beneficiaries who have a body-mass index (BMI)
greater than or equal to 35, have at least one co-morbidity related to obesity
and have been previously unsuccessful with medical treatment for obesity.
This decision also stipulated that covered bariatric surgery procedures are
reasonable and necessary only when performed at facilities that are: (1)
certified by the American College of Surgeons (ACS) as a Level 1 Bariatric
Surgery Center (program standards and requirements in effect on February
15, 2006); or (2) certified by the American Society for Bariatric Surgery
(ASBS) as a Bariatric Surgery Center of Excellence (ESCOE) (program
standards and requirements in effect on February 15, 2006).
There were no additions, deletions, or editorial changes to
Medicare-approved facilities that meet CMS' minimum facility standards
forbariatric surgery that have been certified by ACS and/or ASMBS in the
3-month period. This information is available at
www.cms.gov/MedicareApprovedFacilitie/BSF/list.asp#TopOfPage. For
questions or additional information, contact Sarah Fulton, MHS
(410-786-2749).
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
17:11 Nov 17, 2021
Previous Re-certification
Dates:
07/17/2008; 06/29/2010;
08/14/2012; 09/09/2014;
08/09/2016; 8/15/2018
Korth Shore University
Hospital
300 Community Drive
Manhasset, NY 11030
Ohio State University Hospitals
410 West Tenth Avenue, DN
168 Columbus, OH 43210
Other information:
Joint Commission ID # 7029
Other information:
Joint Commission IV# 3910
Facility Name
EN18NO21.078
Provider
Number
050100
64506
Federal Register / Vol. 86, No. 220 / Thursday, November 18, 2021 / Notices
The Food and Drug
Administration (FDA or Agency) is
withdrawing approval of 18 abbreviated
new drug applications (ANDAs) from
multiple applicants. The applicants
notified the Agency in writing that the
drug products were no longer marketed
and requested that the approval of the
applications be withdrawn.
SUMMARY:
[FR Doc. 2021–25103 Filed 11–17–21; 8:45 am]
BILLING CODE 4120–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–1195]
Approval is withdrawn as of
December 20, 2021.
DATES:
Discovery Therapeutics, LLC, et al.;
Withdrawal of Approval of 18
Abbreviated New Drug Applications
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The
applicants listed in the table have
informed FDA that these drug products
are no longer marketed and have
requested that FDA withdraw approval
of the applications under the process
described in § 314.150(c) (21 CFR
314.150(c)). The applicants have also,
by their requests, waived their
opportunity for a hearing. Withdrawal
of approval of an application or
abbreviated application under
§ 314.150(c) is without prejudice to
refiling.
SUPPLEMENTARY INFORMATION:
Application No.
Drug
Applicant
ANDA 040619 .........
Methimazole Tablets, 15 milligrams (mg) .............................
ANDA 070254 .........
Naloxone Hydrochloride (HCl) Injection, 0.4 mg/milliliters
(mL).
Bupivacaine HCl Injection, 0.25% .........................................
Morphine Sulfate Injection, 1 mg/mL ....................................
Desmopressin Acetate Injection, 0.004 mg/mL ....................
Tretinoin Cream, 0.05% ........................................................
Ciprofloxacin Injection, 200 mg/20 mL (10 mg/mL) and 400
mg/40 mL (10 mg/mL).
Lidocaine HCl Solution, 4% ...................................................
Chloroprocaine HCl Injection, 3% .........................................
Chloroprocaine HCl Injection, 2% .........................................
Levocetirizine Dihydrochloride Tablets, 5 mg .......................
Discovery Therapeutics, LLC, 2831 Deer Hound Way, Palm
Harbor, FL 34683.
Hospira, Inc., 275 North Field Dr., Building H1, Lake Forest, IL 60045.
Do.
Do.
Do.
ZO Skin Health, Inc., 9685 Research Dr., Irvine, CA 92618.
Hospira, Inc.
ANDA
ANDA
ANDA
ANDA
ANDA
070586
071850
075220
076498
077245
.........
.........
.........
.........
.........
ANDA
ANDA
ANDA
ANDA
080409
087446
087447
201653
.........
.........
.........
.........
ANDA 202524 .........
ANDA 202857 .........
ANDA 203885 .........
ANDA 207864 .........
ANDA 209489 .........
ANDA 210283 .........
ANDA 210855 .........
khammond on DSKJM1Z7X2PROD with NOTICES
Martha Nguyen, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 1676,
Silver Spring, MD 20993–0002, 240–
402–6980, Martha.Nguyen@fda.hhs.gov.
Levetiracetam Extended Release Tablets, 500 mg and 750
mg.
Daptomycin Powder for Injection, 500 mg/vial ......................
Amiodarone HCl Injection, 50 mg/mL ...................................
Eptifibatide Injection, 2 mg/mL and 75 mg/100 mL ..............
Caspofungin Acetate Powder for Injection, 50 mg/vial and
70 mg/vial.
Clofarabine Injection, 20 mg/20 mL (1 mg/mL) ....................
Sodium Nitroprusside Injection, 25 mg/mL ...........................
Therefore, approval of the
applications listed in the table, and all
amendments and supplements thereto,
is hereby withdrawn as of December 20,
2021. Approval of each entire
application is withdrawn, including any
strengths and dosage forms
inadvertently missing from the table.
Introduction or delivery for introduction
into interstate commerce of products
without approved new drug
applications violates section 301(a) and
(d) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 331(a) and (d)).
Drug products that are listed in the table
that are in inventory on December 20,
2021 may continue to be dispensed
until the inventories have been depleted
or the drug products have reached their
expiration dates or otherwise become
violative, whichever occurs first.
VerDate Sep<11>2014
Do.
Do.
Do.
Sun Pharmaceutical Industries, Inc., U.S. Agent for Sun
Pharmaceutical Industries Ltd., 270 Prospect Plains Rd.,
Cranbury, NJ 08512.
Rouses Point Pharmaceuticals, LLC, 11 Commerce Dr.,
Cranford, NJ 07016.
Hospira, Inc.
Do.
The WhiteOak Group, LLC, U.S. Agent for Hybio Pharmaceutical Co., Ltd., 1629 K St. NW, Suite 300, Washington, DC 20006.
Cipla USA, Inc., U.S. Agent for Cipla Limited, 10 Independence Blvd., Suite 300, Warren, NJ 07059.
Hospira, Inc.
Cipla USA, Inc.
17:11 Nov 17, 2021
Jkt 256001
Dated: November 12, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, including consideration
of personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NICHD.
Name of Committee: Board of Scientific
Counselors, NICHD.
Date: December 3, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: A report by the Acting Scientific
Director, NICHD, on the status of the NICHD
[FR Doc. 2021–25111 Filed 11–17–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\18NON1.SGM
18NON1
Agencies
[Federal Register Volume 86, Number 220 (Thursday, November 18, 2021)]
[Notices]
[Pages 64492-64506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25103]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-9132-N]
Medicare and Medicaid Programs; Quarterly Listing of Program
Issuances--July Through September 2021
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice
-----------------------------------------------------------------------
SUMMARY: This quarterly notice lists CMS manual instructions,
substantive and interpretive regulations, and other Federal Register
notices that were published from July through September 2021, relating
to the Medicare and Medicaid programs and other programs administered
by CMS.
FOR FURTHER INFORMATION CONTACT: It is possible that an interested
party may need specific information and not be able to determine from
the listed information whether the issuance or regulation would fulfill
that need. Consequently, we are providing contact persons to answer
general questions concerning each of the addenda published in this
notice.
------------------------------------------------------------------------
Addenda Contact Phone number
------------------------------------------------------------------------
I CMS Manual Instructions...... Ismael Torres.... (410) 786-1864
II Regulation Documents Terri Plumb...... (410) 786-4481
Published in the Federal
Register.
III CMS Rulings................ Tiffany Lafferty. (410) 786-7548
IV Medicare National Coverage Wanda Belle, MPA. (410) 786-7491
Determinations.
V FDA-Approved Category B IDEs. John Manlove..... (410) 786-6877
VI Collections of Information.. William Parham... (410) 786-4669
VII Medicare-Approved Carotid Sarah Fulton, MHS (410) 786-2749
Stent Facilities.
VIII American College of Sarah Fulton, MHS (410) 786-2749
Cardiology-National
Cardiovascular Data Registry
Sites.
IX Medicare's Active Coverage- JoAnna Baldwin, (410) 786-7205
Related Guidance Documents. MS.
X One-time Notices Regarding JoAnna Baldwin, (410) 786-7205
National Coverage Provisions. MS.
XI National Oncologic Positron David Dolan, MBA. (410) 786-3365
Emission Tomography Registry
Sites.
XII Medicare-Approved David Dolan, MBA. (410) 786-3365
Ventricular Assist Device
(Destination Therapy)
Facilities.
XIII Medicare-Approved Lung Sarah Fulton, MHS (410) 786-2749
Volume Reduction Surgery
Facilities.
XIV Medicare-Approved Bariatric Sarah Fulton, MHS (410) 786-2749
Surgery Facilities.
XV Fluorodeoxyglucose Positron David Dolan, MBA. (410) 786-3365
Emission Tomography for
Dementia Trials.
All Other Information.......... Annette Brewer... (410) 786-6580
------------------------------------------------------------------------
[[Page 64493]]
SUPPLEMENTARY INFORMATION
I. Background
The Centers for Medicare & Medicaid Services (CMS) is responsible
for administering the Medicare and Medicaid programs and coordination
and oversight of private health insurance. Administration and oversight
of these programs involves the following: (1) Furnishing information to
Medicare and Medicaid beneficiaries, health care providers, and the
public; and (2) maintaining effective communications with CMS regional
offices, state governments, state Medicaid agencies, state survey
agencies, various providers of health care, all Medicare contractors
that process claims and pay bills, National Association of Insurance
Commissioners (NAIC), health insurers, and other stakeholders. To
implement the various statutes on which the programs are based, we
issue regulations under the authority granted to the Secretary of the
Department of Health and Human Services under sections 1102, 1871,
1902, and related provisions of the Social Security Act (the Act) and
Public Health Service Act. We also issue various manuals, memoranda,
and statements necessary to administer and oversee the programs
efficiently.
Section 1871(c) of the Act requires that we publish a list of all
Medicare manual instructions, interpretive rules, statements of policy,
and guidelines of general applicability not issued as regulations at
least every 3 months in the Federal Register.
II. Format for the Quarterly Issuance Notices
This quarterly notice provides only the specific updates that have
occurred in the 3-month period along with a hyperlink to the full
listing that is available on the CMS website or the appropriate data
registries that are used as our resources. This is the most current up-
to-date information and will be available earlier than we publish our
quarterly notice. We believe the website list provides more timely
access for beneficiaries, providers, and suppliers. We also believe the
website offers a more convenient tool for the public to find the full
list of qualified providers for these specific services and offers more
flexibility and ``real time'' accessibility. In addition, many of the
websites have listservs; that is, the public can subscribe and receive
immediate notification of any updates to the website. These listservs
avoid the need to check the website, as notification of updates is
automatic and sent to the subscriber as they occur. If assessing a
website proves to be difficult, the contact person listed can provide
information.
III. How To Use the Notice
This notice is organized into 15 addenda so that a reader may
access the subjects published during the quarter covered by the notice
to determine whether any are of particular interest. We expect this
notice to be used in concert with previously published notices. Those
unfamiliar with a description of our Medicare manuals should view the
manuals at https://www.cms.gov/manuals.
The Director of the Office of Strategic Operations and Regulatory
Affairs of the Centers for Medicare & Medicaid Services (CMS), Kathleen
Cantwell, having reviewed and approved this document, authorizes
Trenesha Fultz-Mimms, who is the Federal Register Liaison, to
electronically sign this document for purposes of publication in the
Federal Register.
Dated: November 12, 2021.
Trenesha Fultz-Mimms,
Federal Register Liaison, Department of Health and Human Services.
BILLING CODE 4120-01-P
[[Page 64494]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.067
[[Page 64495]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.068
[[Page 64496]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.069
[[Page 64497]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.070
[[Page 64498]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.071
[[Page 64499]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.072
[[Page 64500]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.073
[[Page 64501]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.074
[[Page 64502]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.075
[[Page 64503]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.076
[[Page 64504]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.077
[[Page 64505]]
[GRAPHIC] [TIFF OMITTED] TN18NO21.078
[[Page 64506]]
[FR Doc. 2021-25103 Filed 11-17-21; 8:45 am]
BILLING CODE 4120-01-C